103 related articles for article (PubMed ID: 10786893)
1. Cancer proteomics: from identification of novel markers to creation of artifical learning models for tumor classification.
Alaiya AA; Franzén B; Auer G; Linder S
Electrophoresis; 2000 Apr; 21(6):1210-7. PubMed ID: 10786893
[TBL] [Abstract][Full Text] [Related]
2. Clinical cancer proteomics: promises and pitfalls.
Alaiya A; Al-Mohanna M; Linder S
J Proteome Res; 2005; 4(4):1213-22. PubMed ID: 16083271
[TBL] [Abstract][Full Text] [Related]
3. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
Yocum AK; Busch CM; Felix CA; Blair IA
J Proteome Res; 2006 Oct; 5(10):2743-53. PubMed ID: 17022645
[TBL] [Abstract][Full Text] [Related]
4. Analysis of polypeptide expression in benign and malignant human breast lesions.
Franzén B; Linder S; Alaiya AA; Eriksson E; Fujioka K; Bergman AC; Jörnvall H; Auer G
Electrophoresis; 1997; 18(3-4):582-7. PubMed ID: 9150945
[TBL] [Abstract][Full Text] [Related]
5. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS.
Pardo M; García A; Thomas B; Piñeiro A; Akoulitchev A; Dwek RA; Zitzmann N
Proteomics; 2005 Dec; 5(18):4980-93. PubMed ID: 16267820
[TBL] [Abstract][Full Text] [Related]
6. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
8. Two-dimensional gel analysis of protein expression in ovarian tumors shows a low degree of intratumoral heterogeneity.
Alaiya AA; Franzén B; Moberger B; Silfverswärd C; Linder S; Auer G
Electrophoresis; 1999; 20(4-5):1039-46. PubMed ID: 10344283
[TBL] [Abstract][Full Text] [Related]
9. Proteomic signature of human cancer cells.
Seike M; Kondo T; Fujii K; Yamada T; Gemma A; Kudoh S; Hirohashi S
Proteomics; 2004 Sep; 4(9):2776-88. PubMed ID: 15352251
[TBL] [Abstract][Full Text] [Related]
10. Epithelial proteomics in multiple organs and tissues: similarities and variations between cells, organs, and diseases.
Zhao H; Adler KB; Bai C; Tang F; Wang X
J Proteome Res; 2006 Apr; 5(4):743-55. PubMed ID: 16602680
[TBL] [Abstract][Full Text] [Related]
11. Proteome- and microarray-based expression analysis of lymphoma cell lines identifies a p53-centered cluster of differentially expressed proteins in mantle cell and follicular lymphoma.
Weinkauf M; Christopeit M; Hiddemann W; Dreyling M
Electrophoresis; 2007 Dec; 28(23):4416-26. PubMed ID: 17990259
[TBL] [Abstract][Full Text] [Related]
12. An introduction into proteomics and its clinical applications.
Ahram M
Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.
Zuidervaart W; Hensbergen PJ; Wong MC; Deelder AM; Tensen CP; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):786-93. PubMed ID: 16505008
[TBL] [Abstract][Full Text] [Related]
14. Cancer proteomics: from biomarker discovery to signal pathway profiling.
Bichsel VE; Liotta LA; Petricoin EF
Cancer J; 2001; 7(1):69-78. PubMed ID: 11269650
[TBL] [Abstract][Full Text] [Related]
15. Artificial neural networks and decision tree model analysis of liver cancer proteomes.
Luk JM; Lam BY; Lee NP; Ho DW; Sham PC; Chen L; Peng J; Leng X; Day PJ; Fan ST
Biochem Biophys Res Commun; 2007 Sep; 361(1):68-73. PubMed ID: 17644064
[TBL] [Abstract][Full Text] [Related]
16. Cancer proteomics: Serum diagnostics for tumor marker discovery.
Rai AJ; Chan DW
Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
[TBL] [Abstract][Full Text] [Related]
17. Independent component analysis-based penalized discriminant method for tumor classification using gene expression data.
Huang DS; Zheng CH
Bioinformatics; 2006 Aug; 22(15):1855-62. PubMed ID: 16709589
[TBL] [Abstract][Full Text] [Related]
18. Proteomics in the analysis of prostate cancer.
Naaby-Hansen S; Nagano K; Gaffney P; Masters JR; Cramer R
Methods Mol Med; 2003; 81():277-97. PubMed ID: 12725127
[No Abstract] [Full Text] [Related]
19. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
[TBL] [Abstract][Full Text] [Related]
20. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Bharti A; Ma PC; Salgia R
Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
